TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
Bioaxter Bioscience AB
Closing information (x1000 SEK)
Closing information | 2021/12 | 2020/12 | 2019/12 |
Turnover |
0
![]() |
0
|
4,857 |
Financial expenses |
0
![]() |
0
|
14 |
Earnings before taxes |
-469
|
2,443
|
162 |
EBITDA |
-367
|
2,544
|
1,318 |
Total assets |
2,190
|
2,728
|
2,819 |
Current assets |
2,054
|
2,490
|
1,645 |
Current liabilities |
75
|
144
|
1,140 |
Equity capital |
2,115
|
2,584
|
1,516 |
- share capital |
50
![]() |
50
![]() |
50 |
Employees (average) |
1
![]() |
1
|
4 |
Financial ratios
Fiscal year | 2021/12 | 2020/12 | 2019/12 |
Solvency |
96.6%
|
94.7%
|
53.8% |
Turnover per employee |
0
![]() |
0
|
1,214 |
Profit as a percentage of turnover | 3.3% | ||
Return on assets (ROA) |
-21.4%
|
89.6%
|
6.2% |
Current ratio |
2738.7%
|
1729.2%
|
144.3% |
Return on equity (ROE) |
-22.2%
|
94.5%
|
10.7% |
Change turnover |
0
|
-4,857
|
-525 |
Change turnover % |
-100%
|
-10% | |
Chg. No. of employees |
0
|
-3
|
0 |
Chg. No. of employees % |
0%
|
-75%
|
0% |
Total value of public sale
Fiscal year | 2021/12 | 2020/12 | 2019/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.